View source for 20240016534. THERMAL HEATING ELEMENT FOR USE WITH ENDOMETRIAL ABLATION simplified abstract (Covidien LP)

=THERMAL HEATING ELEMENT FOR USE WITH ENDOMETRIAL ABLATION=


==Organization Name==

[[:Category:Covidien LP|Covidien LP]]


[[Category:Covidien LP]]

==Inventor(s)==

[[:Category:James D. Allen, Iv of Broomfield CO (US)|James D. Allen, Iv of Broomfield CO (US)]][[Category:James D. Allen, Iv of Broomfield CO (US)]]

[[:Category:William E. Robinson of Boulder CO (US)|William E. Robinson of Boulder CO (US)]][[Category:William E. Robinson of Boulder CO (US)]]

==THERMAL HEATING ELEMENT FOR USE WITH ENDOMETRIAL ABLATION - A simplified explanation of the abstract==


This abstract first appeared for US patent application 20240016534 titled 'THERMAL HEATING ELEMENT FOR USE WITH ENDOMETRIAL ABLATION

==Simplified Explanation==

The patent application describes a device for endometrial ablation, a medical procedure to treat the uterine tissue of a patient. The device includes a selectively expandable bladder that can be inserted through the cervical canal and into the patient's cervix. The bladder has an interior volume that can be filled with a thermally conductive medium. When the medium is introduced, it expands the bladder against the uterine tissue of the cervix.

Key points about the patent/innovation:

* The device includes a selectively expandable bladder that can be inserted through the cervical canal and into the patient's cervix.
* The bladder has an interior volume that can be filled with a thermally conductive medium.
* One or more insulative substrates are placed within the bladder and support a thermal assembly.
* The thermal assembly is coupled to an energy source and conducts thermal energy to a thermally conductive substrate.
* Activation of the thermal assembly heats the thermally conductive medium in contact with the thermally conductive substrate, treating the uterine tissue of the patient.

Potential applications of this technology:

* Endometrial ablation: The device can be used for the treatment of uterine tissue through the application of thermal energy.
* Gynecological procedures: The device can be utilized in various gynecological procedures that require the treatment of uterine tissue.

Problems solved by this technology:

* Minimally invasive procedure: The device allows for a less invasive approach to endometrial ablation, as it can be inserted through the cervical canal without the need for major surgery.
* Precise treatment: The device provides a controlled and targeted delivery of thermal energy to the uterine tissue, ensuring effective treatment while minimizing damage to surrounding tissues.

Benefits of this technology:

* Reduced patient discomfort: The minimally invasive nature of the device can result in reduced pain and discomfort for the patient compared to traditional surgical methods.
* Faster recovery time: The device may lead to a quicker recovery period for patients, as it avoids the need for extensive surgical incisions and reduces the risk of complications.
* Improved treatment outcomes: The precise delivery of thermal energy allows for more effective treatment of uterine tissue, potentially leading to improved patient outcomes.


==Original Abstract Submitted==

a device for endometrial ablation includes a selectively expandable bladder configured for insertion through a cervical canal of a patient and into a patient's cervix. the selectively expandable bladder defines an interior volume for receiving a thermally conductive medium which, when introduced into the interior volume, expands the selectively expandable bladder against the uterine tissue of the cervix. one or more insulative substrates is operably disposed within the interior volume and supports a thermal assembly on the one or more insulative substrates. the thermal assembly couples to an energy source and is configured to conduct thermal energy to a thermally conductive substrate upon activation of the thermal assembly, which, in turn, heats the thermally conductive medium in contact with the thermally conductive substrate to treat the uterine tissue of a patient.



[[Category:A61B18/08]]
[[Category:H05B3/06]]